Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
THE KRE-ALKALYN® EFX DIFFERENCE IT’S BUFFERED. IT’S STABLE. IT WORKS!* SUPPLEMENT FACTS U.S. Patent #6,399,661 New Zealand Patent #519305 Australian Patent #2003203344 Kre-Alkalyn® EFX represent a major breakthrough in performance supplementation thanks to its multi-patented, 'pH-Correct®' creatine stabilization technology. Our scientist discovered that “buffering” to pH-12 produced a stable creatine molecule. Kre-Alkalyn® EFX is the only creatine monohydrate product with a pH of 12 because its molecules are synthesized with ‘buffering’ agents using a patented manufacturing process. Serving Size: 2 Capsules Servings Per Container: 96 Amount Per Serving † Daily Value (DV) not established. SUGGESTED USE: As a dietary supplement, take 1 capsule 30 minutes pre-workout and 1 post-workout. 175 lbs. & ABOVE 2 Caps Before & After Workout -Alkalyn® Kre NA L Co m pan y The ORIGINA PRE-WORKOUT & POST-WORKOUT Tested For Purity And Banned Substances!* L 1 Cap Before & After Workout f ro m t h e O R I GI 160 192 Capsules DIETARY SUPPLEMENT Kre-Alkalyn® is a patented product (US # 6,399,661) and registered trademark of All American Pharmaceutical. Made in the USA. In God We Trust. Manufactured for and distributed by: All American® EFX Bakersfield, CA 93309. Questions about this product? Call: (888) 238-1864 or visit our website: www.aaefx.com. ©2012 All American® EFX 737190001851 UP TO 175 lbs. Buffered. Stable. Patented!* After 60 days, the Kre-Alkalyn® group (using 7.5g per day) experienced an overall average strength increase of 28.25% above those in the unbuffered creatine monohydrate group! *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. STORAGE: Keep lid tightly closed in a cool, dry place away from children. pH-Correct® Creatine!* EU Plant# 1000135313 • AAC8263-192 Twenty-four elite athletes from the Bulgarian National Weightlifting Team† were selected to participate in a double-blind clinical study(1) comparing Kre-Alkalyn® to standard creatine monohydrate. Jeff Golini, (Kre-Alkalyn® Inventor and Patent Holder) † OTHER INGREDIENTS: Gelatin, Maltodextrin, Magnesium Stearate, FD&C Blue #1, FD&C Red #40 FROM THE LAB TO THE GYM!† †Elite athletes using 7.5g of Kre-Alkalyn®. Individual results may vary. Referenced: (1) Stoychev K., Terziiski N. (2006). “Comparison of Kre-Alkalyn to Creatine...performance, & safety”. % DV Kre-Alkalyn® 1,500 mg (buffered creatine monohydrate) U.S. Patent #6,399,661